Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01198821
What this trial is testing

Gem-TABS in Unresectable Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 8
Not applicableStudy completedNCT01466244
What this trial is testing

Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 42
Early research (Phase 1)Study completedNCT00215956
What this trial is testing

A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma

Who this might be right for
Rectal Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 31
Not applicableActive Not RecruitingNCT07556367
What this trial is testing

Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients

Who this might be right for
Head and Neck CancerHead and Neck CarcinomaHead and Neck Neoplasms
University of California, San Francisco 43
Early research (Phase 1)Study completedNCT00514007
What this trial is testing

Study of Continuous OSI-906 Dosing

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Testing effectiveness (Phase 2)Study completedNCT00076609
What this trial is testing

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
PhytoCeutica 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT05681039
What this trial is testing

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Who this might be right for
Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma
M.D. Anderson Cancer Center 29
Not applicableStudy completedNCT06057857
What this trial is testing

Oral Cancer Screening in Workplace: a Cross-sectional Study

Who this might be right for
Oral Cancer
Cairo University 302
Large-scale testing (Phase 3)Active Not RecruitingNCT05948475
What this trial is testing

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc. 200
Testing effectiveness (Phase 2)Study completedNCT00725712
What this trial is testing

Study of GSK1363089 in Metastatic Gastric Cancer

Who this might be right for
Neoplasms, Gastrointestinal Tract
GlaxoSmithKline 74
Testing effectiveness (Phase 2)Study completedNCT00634751
What this trial is testing

CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma

Who this might be right for
Pancreatic NeoplasmsBile Duct Neoplasms
University of Wisconsin, Madison 48
Early research (Phase 1)Study completedNCT02224053
What this trial is testing

Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers

Who this might be right for
Healthy Volunteer
AstraZeneca 136
Testing effectiveness (Phase 2)Study completedNCT02794077
What this trial is testing

Cyclophosphamide for Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Undifferentiated CarcinomaStage IV Nasopharyngeal Undifferentiated Carcinoma
The University of Hong Kong 56
Testing effectiveness (Phase 2)Study completedNCT00096512
What this trial is testing

S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT00006481
What this trial is testing

Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerSkin Reactions Secondary to Radiation Therapy
Radiation Therapy Oncology Group
Not applicableStudy completedNCT02306967
What this trial is testing

Fluorescent Visualization in Early Oral Cancer

Who this might be right for
Oral Squamous Cell Carcinoma or Severe Dysplasia
University of Calgary 40
Not applicableEnded earlyNCT00898430
What this trial is testing

Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00534001
What this trial is testing

Bupropion in Helping Adults Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 95
Not applicableStudy completedNCT01043328
What this trial is testing

Human Papillomavirus on Oral Tissue, Saliva and Serum

Who this might be right for
Squamous Cell Carcinoma
UPECLIN HC FM Botucatu Unesp 80
Large-scale testing (Phase 3)Ended earlyNCT00113399
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 15
Next Page